Education News and Research

RSS

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

The National Vaccine Information Center participated in a meeting sponsored by the federal National Vaccine Advisory Committee and facilitated by The Keystone Center April 11-13 in Salt Lake City to discuss strengthening the U.S. vaccine safety system.

17 Apr 2010

NSF Faculty Early Career Development Award for Zhihao Zhuang

Zhihao Zhuang, assistant professor in the Department of Chemistry and Biochemistry at the University of Delaware, has won the National Science Foundation Faculty Early Career Development Award.

17 Apr 2010

G1 HCV patients having fast antiviral response to TVR with PEG-IFN and RBV can be cured in 24 weeks

24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.

17 Apr 2010

EAU launches new website

The EAU recently launched its new website. Online efforts are continued under the same name: www.uroweb.org. But everything else has been redesigned in line with the latest internet trends - user-friendliness, interactivity, elegance. Prof. Manfred Wirth, EAU Executive Member Communication, says: "The EAU is a dynamic organisation.

17 Apr 2010

New treatment options for patients with SAH

Results from two French studies presented today at the International Liver CongressTM 2010 press conference will help inform clinical practice in the treatment of patients with severe or acute alcoholic hepatitis.

17 Apr 2010

MiRNA-21 interferes with Herceptin therapy, says study

Overexpression of a specific type of microRNA can derail treatment by disabling an important molecular brake on breast cancer cell proliferation, according to evidence presented by researchers from The University of Texas M. D. Anderson Cancer Center at the American Association for Cancer Research 101st Annual Meeting 2010.

17 Apr 2010

Genomic portrait may predict liver cancer recurrence: Study

Results of an international clinical study conducted in Europe and the US presented today at the International Liver CongressTM 2010, the Annual Meeting of the European Association for the Study of Liver in Vienna, Austria, have identified a genomic portrait able to predict recurrence in hepatocellular carcinoma (HCC), the fifth most common cancer in men.

17 Apr 2010

Pennsylvania awarded $1M in Recovery Act funding for managing chronic disease in older citizens

Governor Edward G. Rendell today announced that $1 million from the American Recovery and Reinvestment Act has been awarded to Pennsylvania to prevent and manage chronic disease in older citizens.

17 Apr 2010

Role of race and health insurance status in breast cancer diagnosis and treatment

Researchers at The GW Cancer Institute, with funding from the National Cancer Institute, examined the effect of race and health insurance status on diagnostic and treatment delays over a 5-year period, with initial screenings going back 12 years, and found that race may play a larger role than previously thought when it comes to optimal diagnosis and treatment of black women with breast cancer.

17 Apr 2010

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.

17 Apr 2010

Treatment with high dose UDCA no more effective for NASH: German study

Results of a German study presented today at the International Liver CongressTM 2010, the Annual Meeting of the European Association for the Study of Liver in Vienna, Austria, have shown that overall, treatment with high dose (23-28mg/kg/d) ursodeoxycholic acid is no more effective than placebo in the treatment of non-alcoholic steatohepatitis, the most advanced form of non-alcoholic liver disease associated with cirrhosis of the liver.

17 Apr 2010

Researchers study effectiveness of TeleCare in keeping individuals healthy

Like the bleeps of an alarm clock, TeleCare, a home monitoring device, gives the chronically ill a wake-up call: "It's time to take your vitals."

17 Apr 2010

Victims of SCA treated with AEDs by bystanders have much greater chance of survival

Victims of sudden cardiac arrest who are treated with automated external defibrillators by bystanders have a much greater chance of survival than their counterparts, according to landmark research by the Resuscitation Outcomes Consortium, just published in the Journal of the American College of Cardiology.

16 Apr 2010

Prostate cancer patients having robotic prostatectomy enjoy significant benefits: Study

A new study of almost 700 patients from The Mount Sinai Medical Center shows that prostate cancer patients who had robotically assisted prostatectomy enjoyed significant benefits over patients who had a traditional open radical prostatectomy, including decreased surgical and recovery time, less blood loss during surgery and significantly shorter hospital stays.

16 Apr 2010

Primary care physician practices focus on improving patient outcomes

Patients need help to navigate the health care system and to better manage their own chronic health conditions. New health care delivery models that effectively provide those services have been shown to both lower overall costs and improve patient health.

16 Apr 2010

Socioeconomic factors linked to rates and outcomes of stem cell transplantation for AML patients

The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).

16 Apr 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.

16 Apr 2010

Diagnosis errors have put patient health in danger: NPSA study

The study, which was conducted by the NHS' National Patient Safety Agency, analysed over a thousand cases where cancer had been misdiagnosed or indentified late over a 12-month period.

16 Apr 2010

ASH named fourth healthiest large-group business employer in San Diego county

American Specialty Health Incorporated (ASH), a leading national health and wellness organization, announced that it was named the fourth healthiest large-group business in San Diego county in the first annual "San Diego's Healthiest Employers Awards," produced by the San Diego Business Journal. Certificates were presented to 50 finalists, and only the top five companies in small, medium, and large categories were named as honorees.

16 Apr 2010

ASH to conduct complimentary screenings in NYC

In the wake of the Institute of Medicine's report on hypertension highlighting it as a 'neglected disease' and urging a more focused and collaborative approach to reduce its prevalence, the American Society of Hypertension, Inc. (ASH), will hold its annual complimentary blood pressure screenings and hypertension counseling in at-risk communities across New York City.

16 Apr 2010

Education News and Research

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

NSF Faculty Early Career Development Award for Zhihao Zhuang

G1 HCV patients having fast antiviral response to TVR with PEG-IFN and RBV can be cured in 24 weeks

EAU launches new website

New treatment options for patients with SAH

MiRNA-21 interferes with Herceptin therapy, says study

Genomic portrait may predict liver cancer recurrence: Study

Pennsylvania awarded $1M in Recovery Act funding for managing chronic disease in older citizens

Role of race and health insurance status in breast cancer diagnosis and treatment

Multinational phase II study: GS-9450 can reduce markers of liver damage in patients with NASH

Treatment with high dose UDCA no more effective for NASH: German study

Researchers study effectiveness of TeleCare in keeping individuals healthy

Victims of SCA treated with AEDs by bystanders have much greater chance of survival

Prostate cancer patients having robotic prostatectomy enjoy significant benefits: Study

Primary care physician practices focus on improving patient outcomes

Socioeconomic factors linked to rates and outcomes of stem cell transplantation for AML patients

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Diagnosis errors have put patient health in danger: NPSA study

ASH named fourth healthiest large-group business employer in San Diego county

ASH to conduct complimentary screenings in NYC

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News